Conmed (CNMD) Receivables (2010 - 2026)

Conmed (CNMD) has reported Receivables for 17 consecutive years, with $239.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables rose 2.4% year-over-year to $239.8 million; the trailing twelve-month figure through Jun 2026 stood at $239.8 million (up 2.4% YoY), and the FY2025 full-year result was $247.8 million, up 4.25% from the prior year.
• Receivables grew to $239.8 million in Q2 2026 per CNMD's latest filing, from $228.7 million in the prior quarter.
• Across five years, Receivables topped out at $247.8 million in Q4 2025 and bottomed at $183.2 million in Q1 2022.
• Historically, Receivables has averaged $224.2 million across 5 years, with a median of $229.7 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Receivables rose 26.62% in 2023, then declined 8.42% in 2025.
• Over 5 years, Receivables stood at $191.3 million in 2022, then rose by 26.62% to $242.3 million in 2023, then decreased by 1.88% to $237.7 million in 2024, then advanced by 4.25% to $247.8 million in 2025, then decreased by 3.25% to $239.8 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $239.8 million, $228.7 million, and $247.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.